Spearheading the First-in-Class Treatment for Alopecia Areata through JAK Inhibition

Time: 2:00 pm
day: Day 1 PM - Track B


  • Comprehending how the underlying mechanism for alopecia makes JAKis good candidates for therapy
  • Discussing the biomarkers of treatment response and patient selection
  • Addressing the safety concerns and translating our current understanding to best inform patients